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Abstract. Abdominal aortic aneurysms are indolent but deadly. Among the current treatments is 
endovascular aneurysm repair, a minimally invasive procedure that resorts to a stent-graft to shield 
the aortic wall from blood pressure. Although this procedure allowed more patients to be treated and 
offers several other advantages, complications still occur and there is a need for a more efficient 
stent-graft. Here, the early steps performed in the development of a novel stent-graft are described, 
and desired features for an ‘ideal’ device are pointed out. The implementation of these characteristics 
will lead to a more efficient medical device. 
1. Introduction 
In 1948, Albert Einstein was diagnosed with an abdominal aortic aneurysm (AAA or triple A), i.e., 
his aorta had a permanent and irreversible localized dilatation having at least a 50% increase in 
diameter compared with the normal one [1]. Like him, currently, it is estimated that more than 12 per 
100 000 persons-year [2] are affected by this relatively indolent but serious condition. 
In an attempt to reinforce the aortic wall and delay the inevitable rupture that took Einstein’s life in 
1955, Dr. Rudolph Nissen wrapped the visible anterior portion of the aneurysm with polyethene 
cellophane. Nowadays, more effective treatments are offered, namely open surgery, laparoscopy or 
assisted laparoscopy, and endovascular aneurysm repair (EVAR). The treatment is selected 
considering the technology available in the medical center, the anatomy of the aneurysm, the 
operative risk of repair and the patients’ life expectancy. 
Open surgery is an invasive procedure in which the diseased segment of the aorta is replaced by a 
synthetic graft. Total laparoscopy and assisted laparoscopy are two recent minimally invasive 
procedures with similar purposes to those of open surgery [3]. 
EVAR was introduced in the early 1990s and is a minimally invasive procedure in which an 
endoprosthesis, known as stent-graft, is guided from the femoral artery to the affected artery segment. 
The objective of this procedure is to shield the aneurysm sac from the blood pressure, thus preventing 
the rupture of the artery wall. Although this technique is associated with advantages such as shortened 
hospital stays, accelerated recovery and early return to full activity, complications still occur (Table 
1), requiring life-long surveillance of patients [4]. The current surveillance protocol involves imaging 
exams, namely ultrasound and computed tomography angiography (CTA), at 1, 6, and 12 months 
after the procedure, and thereafter, on an annual basis [3]. 
The introduction of EVAR revolutionized the treatment of aortic aneurysms by allowing more 
patients to be treated. However, after 20 years of use, questions are being raised regarding the 
follow-up costs [5]. Thus, in order to reduce EVAR’s follow-up costs that are mainly driven by 
imaging exams, it was suggested the development of a smart stent-graft, i.e., a stent-graft with some 
in-device mechanism to perform a given function with communication capabilities to an external 
element. Here, the methodology adopted to develop the new device is introduced along with the 
results obtained during first steps. 
Table 1. Usual complications involving stent-grafts (adapted from [4]). 
Early complications Late complications 
Graft kink 
Endoleaks 
Graft explantation 
Structural failure 
Graft infection 
Graft migration 
Neck dilatation 
Endoleaks 
Structural failure: component separation, fabric tears, hook fractures 
 
2. Planning the development of a novel stent-graft 
The planning of the development of the novel stent-graft followed the product development 
methodology described by Ulrich et al. [6]. The activities that should be carried out are summarized 
in Fig. 1. 
 
Fig. 1. Planning of the development of the smart stent-graft. 
The opportunity had been identified earlier, and it was to reduce EVAR’s follow-up costs. Taking 
into account the incidence rate of AAA and the number of EVARs performed annually, the project 
was considered attractive. The project’s mission statement is presented in Table 2. 
Table 2. Mission statement regarding the development of the smart stent-graft. 
Product description 
A stent-graft with a sensing mechanism to perform a given function (e.g., measure 
intraluminal pressure) with communication capabilities to an external element 
Key business goals Develop a proof of concept 
Assumptions and 
constrains 
Improve the performance of the current stent-grafts applying different materials 
Apply a flexible sensing technology 
Stakeholders 
Vascular surgeons and physicians 
Patients with aortic aneurysms 
 
3. Concept development of a novel stent-graft 
With the definition of the mission statement, the concept development stage began. The medical 
condition (aortic aneurysms) was studied, and the existing stent-grafts and their materials were 
identified and analyzed [7]. To identify new stent-grafts designs, patents and scientific journals were 
reviewed. 
The requirements for the new device were gathered by reviewing the literature and conducting 
surveys and interviews. The literature provided information about the disease and its incidence as 
well as the most common causes of failure in current devices and suggestions for future research. The 
surveys were administered to patients and healthcare professionals and aimed to identify the 
stent-graft’s characteristics and the customer’s willingness to adopt a smart device. 
The questionnaire to healthcare professionals was prepared in English and Portuguese and was 
accessible through the web. Between June 2010 and February 2011, links to the surveys were 
available in a blog specifically created to divulge the project but no answers were obtained. The link 
was then sent by email to several vascular surgeons and physicians, and 65 answers were gathered. 
The answers came from Europe, North America and Africa, and the majority of the respondents 
(77%) was never involved in the development of a medical device. The factors considered in the 
selection of a stent-graft and their relevance are displayed in Fig. 2. 
 
Fig. 2.Criteria considered during the selection of a stent-graft and their relevance. 
(Question: When selecting a stent-graft, what is the relevance of the following factors?; Total answers: 65) 
To the question “What do you value in a stent-graft?”, the respondents answered that they value 
most flexibility, fixation and the delivery profile (Fig. 3). These answers were consistent with the 
ones given to the open question “What changes would you introduce in the stent-grafts that you 
use?”. 
The respondents of this survey do not follow the current surveillance protocol; they adopted one 
with different exam periodicities and even diagnostic tools. However, they consider the exam process 
that they follow effective, reliable and practical (Fig. 4). 
As far as the identification of complications is concerned, the results do not indicate a trend (Fig. 
5) but the majority of the respondents (83%) considers the use of a smart stent-graft advantageous and 
would like to obtain information about the stent-graft migration (Fig. 6). 
Like the questionnaire to the healthcare professionals, the survey to patients was also prepared in 
English and Portuguese and was available through the web. The links were also available in the blog, 
but again no answers were obtained. Thus, three Portuguese hospitals with vascular surgery (H.S. 
João in Porto, H.U.C. in Coimbra and H.S. Marta in Lisbon) were contacted to administer the survey 
to their patients. To interact with patients, the three hospitals required that the questionnaire was 
approved by the Ethics Committee (a process that took about a year to conclude). Upon approval, the 
patients of H.S. João and HUC were interviewed while waiting for their appointment. In the latter, 
some surveys were filled during the appointment with a doctor. At H.S. Marta, the surveys were 
distributed during the appointments by the doctor and the answers returned by postal mail. 
From the 87 patients questioned, only 21 had an aneurism in the aorta (either thoracic or 
abdominal). Every patient said that the surgeon decided the treatment and which stent-graft should be 
used. Although the majority (86%) was not afraid of performing imaging exams, they feel 
uncomfortable while doing them (76%). 95% of the respondents would ask his doctor for a smart 
stent-graft. 
 
Fig. 3: Valuation of the stent-graft’s characteristics. 
(Question: What do you value in a stent-graft?; Total answers: 65) 
 
Fig. 4: Description of the EVAR follow-up protocol. 
(Question: How would you describe the exam process?; Total answers: 65) 
 
 
Fig. 5: Difficulty in the detection of complications. 
(Question: How would you classify the identification of the following problems?; Total answers: 65) 
The requirements gather during the literature review and the surveys were then classified in 
accordance with the Kano Model [8], [9]; the results are summarized in Table 3. 
 
Fig. 6: Information provided by a smart stent-graft. 
(Question: Which information would you like to obtain from a stent-graft?; Total answers: 65) 
Table 3. Requirements for the smart stent-graft 
Must-be 
Biocompatible and biostable 
Non toxic, allergic and carcinogenic 
Not cause thrombosis and hemolysis 
Not cause inflammatory reaction or foreign body reaction 
Exceed patient life expectancy 
Flexible, ductile and fatigue resistant 
Stable configuration 
Resistant to corrosion, wear and tear 
Radial force enough to ensure fixation and avoid leaks 
Radiopaque 
Sterilizable 
Storable as an "off-the-shelf" product 
Manufacture environmentally accepted 
Satisfier 
Zero porosity 
Predictable behavior 
Wide range of diameters and lengths 
Low profile 
Delighter 
Minimizes flow resistance and pressure drops  
Indicates the intraluminal pressure (systolic and diastolic) 
Indicates the pressure inside the aneurysm sac at several points 
Indicates if stent-graft migrates 
Indicates if module disconnects 
Indicates stent fractures 
Indicates if graft tears 
Indicates blood flow 
4. Summary 
Although the follow-up costs of EVAR represent a disadvantage to the procedure, they also signify an 
opportunity to develop a new stent-graft; namely, one that has some in-device mechanism to perform 
a given function with communication capabilities to an external element. So, the development of the 
novel device was planned using a product development methodology. 
To identify the desired features of the novel device, a literature review was performed, and both 
patients and physicians were interviewed. Although the patients are the users, they are not usually 
involved in the selection of the device adopted; physicians are to the ones that decide which device 
should be employed. 
Physicians are looking for stent-grafts with better flexibility and fixation. As far as the information 
they would like to receive from the stent-graft, they are interested to know if the device is migrating. 
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